James Nelson - 23 Nov 2024 Form 4 Insider Report for Co-Diagnostics, Inc. (CODX)

Role
Director
Signature
/s/ James Nelson
Issuer symbol
CODX
Transactions as of
23 Nov 2024
Transactions value $
$0
Form type
4
Date filed
25 Nov 2024, 16:01
Previous filing
28 May 2024
Next filing
27 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CODX Common Stock Award $0 +48.3K +42.03% $0.00 163K 23 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CODX Restricted Stock Unit Options Exercise $0 -48.3K -24.17% $0.00 152K 23 Nov 2024 Common Stock 200K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Included in 70,000 restricted stock units awarded to the Reporting Person on July 7, 2022, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2022. Included in 40,000 restricted stock units awarded to the Reporting Person on January 17, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on May 23, 2023. Included in 70,000 restricted stock units awarded to the Reporting Person on June 12, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2023. Included in 110,000 restricted stock units awarded to the Reporting Person on April 26, 2024, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2024.